Abstract
Adjuvant aromatase inhibitors (AI) therapy in breast cancer accelerates bone loss resulting in increased incidence of fracture. We evaluated the effect of AI on bone density changes among breast cancer patients in our cancer centre.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 International Federation for Medical and Biological Engineering
About this paper
Cite this paper
Almatari, M., Moe, M., Ali, P., Willshaw, P. (2009). Bone Density Changes during Adjuvant Aromatase Inhibitor Treatment in Breast Cancer Patients: Single Centre Experience. In: Dössel, O., Schlegel, W.C. (eds) World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany. IFMBE Proceedings, vol 25/2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03879-2_259
Download citation
DOI: https://doi.org/10.1007/978-3-642-03879-2_259
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03878-5
Online ISBN: 978-3-642-03879-2
eBook Packages: EngineeringEngineering (R0)